Globeflex Capital »

Amicus Therapeutics shares owned by Globeflex Capital

Quarter-by-quarter ownership of Amicus Therapeutics (FOLD) shares owned by Globeflex Capital from 13F filings

Historical chart of Globeflex Capital investment in Amicus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Amicus Therapeutics held by Globeflex Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amicus Therapeutics by Globeflex Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.2M 87k 14.24

More positions owned by Globeflex Capital

Intercorp Financial Services (IFS)
Exelixis (EXEL)
Copa Holdings Sa-class A (CPA)
Universal Health Services (UHS)
Tenet Healthcare Corporation (THC)
NCR Atleos Corp (NATL)
Rigel Pharmaceuticals (RIGL)
Blue Bird Corp (BLBD)
Cirrus Logic (CRUS)
EnerSys (ENS)
Allegheny Technologies Incorporated (ATI)
Marex Group (MRX)
Phibro Animal Health Corporati*on Cmn Class A (PAHC)
Ypf Sa (YPF)
Ibex (IBEX)

View all positions for Globeflex Capital

Top funds holding Amicus Therapeutics

BlackRock
Vanguard Group
Wellington Management Company
State Street Corporation
Millennium Management
Bellevue Group
William Blair Investment Management
Citadel Advisors
Geode Capital Management
Perceptive Advisors
Goldman Sachs Group
UBS Group
Palo Alto Investors
Soleus Capital Management
Soros Fund Management

View all funds holding Amicus Therapeutics